25
total announcements
VAISHALI.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹98 Cr
EPS (TTM)
₹0.00
52W Low
₹4.75
52W High
₹11.15
Dividend Yield
0.00%
Beta
0.36
Price / Book
1.4
Debt / Equity
27.3
Revenue (TTM)
₹108 Cr
Gross Margin
12.40%
Operating Margin
5.89%
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange regarding allotment of 45,37,865 securities pursuant to Preferential Issue at its meeting held on July 03, 2026.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 02, 2026. The Board has approved an increase in Authorised Share Capital from INR. 27,00,00,000 to INR. 29,00,00,000, and deferred the proposal relating to the Issue and Allotment of 61,23,000 equity shares.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, due to consideration of Un-audited Financial Result for the First Quarter Ended 30th June, 2026.
Vaishali Pharma Limited
Vaishali Pharma Limited has been asked by the NSE to clarify its financial results for the quarter ended 31-Mar-2026, specifically regarding the non-submission of the consolidated statement of cash flow.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange about General Updates, clarifying the consideration for the issuance of up to 61,23,000 equity shares to Kesar Pharma Limited, ensuring alignment with the valuation determined by the Registered Valuer.